Adult stem cell
Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικóς, of the body) stem cells, they can be found in children, as well as adults.
Research into adult stem cells has been fueled by their abilities to divide or self-renew indefinitely and generate all the cell types of the organ from which they originate — potentially regenerating the entire organ from a few cells. Unlike embryonic stem cells, the use of adult stem cells in research and therapy is not controversial because the production of adult stem cells does not require the destruction of an embryo. Adult stem cells can be isolated from a tissue sample obtained from an adult. They have mainly been studied in humans and model organisms such as mice and rats.
- 1 Adult stem cell therapies
- 2 Adult Stem Cell and Cancer
- 3 Properties
- 4 Types
- 5 Open questions in adult stem cell research
- 6 News and External links
- 7 References
Adult stem cell therapies
Due to the ability of adult stem cells to be harvested from the patient, their therapeutic potential is the focus of much research.    Adult stem cells, similar to embryonic stem cells, have the ability to differentiate into more than one cell type, but unlike embryonic stem cells they are often restricted to certain lineages. The ability of a stem cell of one lineage to become another lineage is called transdifferentiation. Different types of adult stem cells are capable of transdifferentiation more than others, and for many there is no evidence of its occurrence. Consequently, adult stem therapies require a stem cell source of the specific lineage needed and harvesting and or culturing them up to the numbers required is a challenge.  
Pluripotent adult stem cells are rare and generally small in number but can be found in a number of tissues including umbilical cord blood. Most adult stem cells are lineage-restricted (multipotent) and are generally referred to by their tissue origin (mesenchymal stem cell, adipose-derived stem cell, endothelial stem cell, etc.).
A great deal of adult stem cell research has focused on clarifying their capacity to divide or self-renew indefinitely and their differentiation potential. In mice, pluripotent stem cells can be directly generated from adult fibroblast cultures.
Adult stem cell treatments have been used for many years to treat successfully leukemia and related bone/blood cancers through bone marrow transplants. The use of adult stem cells in research and therapy is not as controversial as embryonic stem cells, because the production of adult stem cells does not require the destruction of an embryo. Consequently, more US government funding is being provided for adult stem cell research.
Adult Stem Cell and Cancer
In recent years the concept of adult stem cell has transformed to include the theory that stem cells reside in many adult tissues and that these unique reservoir of adult stem cells are not only responsible for the normal reparative and regenerative processes but are also considered to be a prime target for genetic and epigenetic changes culminating to many abnormal conditions including cancer. .
The rigorous definition of a stem cell requires that it possesses two properties:
- Self-renewal - the ability to go through numerous cycles of cell division while maintaining the undifferentiated state.
- Multipotency or multidifferentiative potential - the ability to generate progeny of several distinct cell types, for example both glial cells and neurons, opposed to unipotency - restriction to a single-cell type. Some researchers do not consider this property essential and believe that unipotent self-renewing stem cells can exist.
These properties can be illustrated with relative ease in vitro, using methods such as clonogenic assays, where the progeny of single cell is characterized. However, in vitro cell culture conditions can alter the behavior of cells. Proving that a particular subpopulation of cells possesses stem cell properties in vivo is challenging. Considerable debate exists whether some proposed cell populations in the adult are indeed stem cells.
To ensure self-renewal, stem cells undergo two types of cell division (see Stem cell division and differentiation diagram). Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division, on the other hand, produces only one stem cell and a progenitor cell with limited self-renewal potential. Progentiors can go through several rounds of cell division before terminally differentiating into a mature cell. It is believed that the molecular distinction between symmetric and asymmetric divisions lies in differential segregation of cell membrane proteins (such as receptors) between the daughter cells.
Adult stem cells express transporters of the ATP-binding cassette family that actively pump a diversity of organic molecules out of the cell. Many pharmaceuticals are exported by these transporters conferring multidrug resistance onto the cell. This complicates the design of drugs, for instance neural stem cell targeted therapies for the treatment of clinical depression.
Adult stem cell research has been focused on uncovering the general molecular mechanisms that control their self-renewal and differentiation.
- The transcriptional repressor Bmi-1 is one of the Polycomb-group proteins that was discovered as a common oncogene activated in lymphoma and later shown to specifically regulate HSCs. The role of Bmi-1 has also been illustrated in neural stem cells.
- The Notch pathway has been known to developmental biologists for decades. Its role in control of stem cell proliferation has now been demonstrated for several cell types including haematopoietic, neural and mammary stem cells.
- These developmental pathways are also strongly implicated as stem cell regulators.
Under special conditions tissue-specific adult stem cells can generate a whole spectrum of cell types of other tissues, even crossing germ layers. This phenomenon is referred to as stem cell transdifferentiation or plasticity. It can be induced by modifying the growth medium when stem cells are cultured in vitro or transplanting them to an organ of the body different from the one they were originally isolated from. There is yet no consensus among biologists on the prevalence and physiological and therapeutic relevance of stem cell plasticity.
Adipose derived adult stem cells
Adipose-derived stem cells (ASCs) have also been isolated from human fat, usually by method of liposuction. This cell population seems to be similar in many ways to mesenchymal stem cells (MSCs) derived from bone marrow. However, it is possible to isolate many more cells from adipose tissue and the harvest procedure itself is less painful than the harvest of bone marrow. Human ASCs have been shown to differentiate in the lab into bone, cartilage, fat, muscle, and might be able to differentiate into neurons, making them a possible source for future applications in the clinic. In support of this, current studies in animals suggest that ASCs might be able to repair significant bony defects and ASCs have been recently used to successfully repair a large cranial defect in a human patient .
Haematopoietic stem cells
Mammary stem cells
Mammary stem cells provide the source of cells for growth of the mammary gland during puberty and gestation and play an important role in carcinogenesis of the breast. Mammary stem cells have been isolated from human and mouse tissue as well as from cell lines derived from the mammary gland. A single such cell can give rise to both luminal and myoepithelial cell types of the gland and has been shown to regenerate the entire organ in mice.
Mesenchymal stem cells
Neural stem cells
The existence of stem cells in the adult brain has been postulated following the discovery that the process of neurogenesis, birth of new neurons, continues into adulthood in rats. It has since been shown that new neurons are generated in adult mice, songbirds and primates, including humans. Normally adult neurogenesis is restricted to the subventricular zone, which lines the lateral ventricles of the brain, and the dentate gyrus of the hippocampal formation. Although the generation of new neurons in the hippocampus is well established, the presence of true self-renewing stem cells there has been debated. Under certain circumstances, such as following tissue damage in ischemia, neurogenesis can be induced in other brain regions, including the neocortex.
Neural stem cells are commonly cultured in vitro as so called neurospheres - floating heterogeneous aggregates of cells, containing a large proportion of stem cells. They can be propagated for extended periods of time and differentiated into both neuronal and glia cells, and therefore behave as stem cells. However, some recent studies suggest that this behaviour is induced by the culture conditions in progenitor cells, the progeny of stem cell division that normally undergo a strictly limited number of replication cycles in vivo. Furthermore, neurosphere-derived cells do not behave as stem cells when transplanted back into the brain.
Neural stem cells share many properties with haematopoietic stem cells (HSCs). Remarkably, when injected into the blood, neurosphere-derived cells differentiate into various cell types of the immune system. Cells that resemble neural stem cells have been found in the bone marrow, the home of HSCs. It has been suggested that new neurons in the dentate gyrus arise from circulating HCSs. Indeed, newborn cells first appear in the dentate in the heavily vascularised subgranular zone immediately adjacent to blood vessels.
Olfactory adult stem cells
- Adult stem cells isolated from the olfactory mucosa (cells lining the inside of the nose involved in the sense of smell) have the ability to develop into many different cell types if they are given the right chemical environment.
- These adult olfactory stem cells appear to have the same ability as embryonic stem cells in giving rise to many different cell types but have the advantage that they can be obtained from all individuals, even older people who might be most in need of stem cell therapies.
Olfactory stem cells hold potential for therapeutic applications. Thanks to their location they can be harvested with ease without harm to the patient in contrast to neural stem cells.
Open questions in adult stem cell research
- What is the origin of adult stem cells? They are derived with no medical risk to the donor from blood, umbillical cord blood, bone marrow, placentas, liver, epidermis, retina, skeletal muscle, intestine, brain, dental pulp, and fat obtained from liposuction. They can also be derived from amnionic fluid, non-living fetal tissue and can be extracted from brains of cadavers.
- Are stem cells found in different tissues fundamentally distinct, or is there a universal adult stem cell? Stem cells derived from different adult tissue can have remarkably similar properties. Research on adult stem cells has revealed that they can be induced to produce cell types of a variety of tissues. Do some or all adult stem cells belong to a single lineage but behave differently depending on extracellular cues?
- Which adult tissues harbor stem cells? Do tissues that apparently contain no stem cells rely on other sources of new cells, or is it a matter of time until stem cells are identified there?
- What molecular factors enable stem cell plasticity? While a lot is known about the cellular qualities that accompany multi- and pluripotency, the molecular/genetic factors that determine these qualities remain unclear. Could knowledge of these mechanisms allow us to reverse the process of differentiation and restore embryonic stem cell properties in adult stem cells or even differentiated cells?
- NIH Stem Cell Information Resource, resource for stem cell research
- Stem Cells, the international journal for cell differentiation and proliferation
- Stem Cell and Cord Blood information database
- Check The Score, Successes of Adult Stem Cells vs. Embryonic Stem Cells
- whaaz a science wiki site for updates on stem cells and other related topics
- Cells Limited providing Adult Stem Cells Storage
- Regenecell Adult stem cell treatments worldwide
- Tulane University Centre for Gene Therapy, prepares and distributes marrow stromal cells for academic research
- UMDNJ Stem Cell and Regnerative Medicine, provides educational materials and research resources
- [Adult stem or progenitor cells in treatment for type 1 diabetes: current progress, Can J Surg, Vol. 50, No. 2, April 2007]
- [Stem Cells: A Revolution in Therapeutics—Recent Advances in Stem Cell Biology and Their Therapeutic Applications in Regenerative Medicine and Cancer Therapies, Clinical Pharmacology & Therapeutics (2007) 82, 252–264;]
- [Stem Cells and Their Potential in Cell-Based Cardiac Therapies,Progress in Cardiovascular Diseases Volume 49, Issue 6, May-June 2007, Pages 396-413]
- [ADULT STEM CELL PLASTICITY: Fact or Artifact?, Annual Review of Cell and Developmental Biology Vol. 19: 1-22]
- Versus Embryonic Stem Cells: Treatments, Science 8 June 2007:Vol. 316. no. 5830, pp. 1422 - 1423
- Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M (2007). "A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues". Leukemia. 21 (5): 860–7. doi:10.1038/sj.leu.2404630. PMID 17344915.
- Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC (2006). "Review: ex vivo engineering of living tissues with adult stem cells". Tissue Eng. 12 (11): 3007–19. doi:10.1089/ten.2006.12.3007. PMID 17518617.
- Gimble JM, Katz AJ, Bunnell BA (2007). "Adipose-derived stem cells for regenerative medicine". Circ. Res. 100 (9): 1249–60. doi:10.1161/01.RES.0000265074.83288.09. PMID 17495232.
- Gardner RL (2002). "Stem cells: potency, plasticity and public perception". Journal of Anatomy. 200 (3): 277–82. doi:10.1046/j.1469-7580.2002.00029.x. PMID 12033732.
- Takahashi K, Yamanaka S (2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell. 126 (4): 663–76. doi:10.1016/j.cell.2006.07.024. PMID 16904174.
- , Bone Marrow Transplant
- ,USDHHS Stem Cell FAQ 2004
- Chaudhary PM and Roninson IB (1991). "Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells". Cell. 66 (1): 85–94. Entrez PubMed 1712673
- Haupt Y, Bath ML, Harris AW and Adams JM (1993). "bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis". Oncogene. 8: 3161–3164.Entrez PubMed 8414519
- Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ and Clarke MF (2003). "Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells". Nature. 423: 302–305.Entrez PubMed 12714971
- Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF and Morrison SJ (2003). "Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation". Nature. 425: 962–967.Entrez PubMed 14574365
- Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM and Wicha MS (2004). "Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells". Breast Cancer Res. 6: R605–615.PMC 1064073
- Beachy PA, Karhadkar SS and Berman DM (2004). "Tissue repair and stem cell renewal in carcinogenesis". Nature. 432: 324–331. Entrez PubMed 15549094
- Filip S, English D and Mokry J (2004). "Issues in stem cell plasticity". J Cell Mol Med. 8 (4): 572–577. Entrez PubMed 15601587
- Zuk PA, Zhu M, Mizuno H, Huang JI, Chaudhari S, Lorenz HP, Benhaim P and Hedrick MH (2001). "Mutilineage cells derived from human adipose tissue: a putative source of stem cells for tissue engineering". Tissue Engineering. 7 (2): 211–216.
- Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P and Hedrick MH (2002). "Human adipose tissue is a source of multipotent stem cells". Mol Biol Cell. 13: 4279–4295.
- Liu S, Dontu G and Wicha MS (2005). "Mammary stem cells, self-renewal pathways, and carcinogenesis". Breast Cancer Res. 7 (3): 86–95. Entrez PubMed 15987436
- Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ and Visvader JE (2005). "Mammary stem cells, self-renewal pathways, and carcinogenesis". Breast Cancer Res. 7 (3): 86–95.Entrez PubMed 15987436
- Altman J and Das GD (1965). "Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats". J Comp Neurol. 124 (3): 319–335. Entrez PubMed 5861717
- Alvarez-Buylla A, Seri B, Doetsch F (2002). "Identification of neural stem cells in the adult vertebrate brain". Brain Res Bull. 57 (6): 751–758.Entrez PubMed 12031271
- Bull ND and Bartlett PF (2005). "The adult mouse hippocampal progenitor is neurogenic but not a stem cell". J Neurosci. 25 (47): 10815–10821. Entrez PubMed 16306394
- Reynolds BA and Weiss S (1992). "Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system". Science. 255: 1707–1710. Entrez PubMed 1553558
- Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM and Alvarez-Buylla A (2002). "EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells". Neuron. 36 (6): 1021–1034.Entrez PubMed 12495619
- Marshall GP 2nd, Laywell ED, Zheng T, Steindler DA and Scott EW (2006). "In vitro-derived "neural stem cells" function as neural progenitors without the capacity for self-renewal". Stem Cells. 24 (3): 731–738.Entrez PubMed 16339644
- Bjornson CR, Rietze RL, Reynolds BA, Magli MC and Vescovi AL (1999). "Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo". Science. 283: 534–537.Entrez PubMed 9915700
- Kucia M, Zhang YP, Reca R, Wysoczynski M, Machalinski B, Majka M, Ildstad ST, Ratajczak J, Shields CB and Ratajczak MZ (2006). "Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke". Leukemia. 20 (1): 18–28.Entrez PubMed 16270036
- Murrell W, Feron F, Wetzig A, Cameron N, Splatt K, Bellette B, Bianco J, Perry C, Lee G and Mackay-Sim A (2005). "Multipotent stem cells from adult olfactory mucosa". Dev Dyn. 233 (2): 496–515.Entrez PubMed 15782416